TRDA
Price
$6.88
Change
-$0.18 (-2.55%)
Updated
Jun 26, 01:36 PM (EDT)
Capitalization
267.95M
41 days until earnings call
TSHA
Price
$2.38
Change
-$0.06 (-2.46%)
Updated
Jun 26, 01:44 PM (EDT)
Capitalization
638.13M
53 days until earnings call
Interact to see
Advertisement

TRDA vs TSHA

Header iconTRDA vs TSHA Comparison
Open Charts TRDA vs TSHABanner chart's image
Entrada Therapeutics
Price$6.88
Change-$0.18 (-2.55%)
Volume$228
Capitalization267.95M
Taysha Gene Therapies
Price$2.38
Change-$0.06 (-2.46%)
Volume$479
Capitalization638.13M
TRDA vs TSHA Comparison Chart in %
Loading...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRDA vs. TSHA commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRDA is a Buy and TSHA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (TRDA: $7.06 vs. TSHA: $2.44)
Brand notoriety: TRDA and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRDA: 89% vs. TSHA: 49%
Market capitalization -- TRDA: $267.95M vs. TSHA: $638.13M
TRDA [@Biotechnology] is valued at $267.95M. TSHA’s [@Biotechnology] market capitalization is $638.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRDA’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • TRDA’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRDA’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • TRDA’s TA Score: 4 bullish, 4 bearish.
  • TSHA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both TRDA and TSHA are a good buy in the short-term.

Price Growth

TRDA (@Biotechnology) experienced а +0.43% price change this week, while TSHA (@Biotechnology) price change was -5.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

TRDA is expected to report earnings on Aug 06, 2025.

TSHA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($638M) has a higher market cap than TRDA($268M). TRDA has higher P/E ratio than TSHA: TRDA (12.17) vs TSHA (2.70). TSHA YTD gains are higher at: 41.040 vs. TRDA (-59.167). TRDA has higher annual earnings (EBITDA): 7.89M vs. TSHA (-85.47M). TRDA has more cash in the bank: 383M vs. TSHA (117M). TRDA has less debt than TSHA: TRDA (57M) vs TSHA (61.4M). TRDA has higher revenues than TSHA: TRDA (172M) vs TSHA (7.22M).
TRDATSHATRDA / TSHA
Capitalization268M638M42%
EBITDA7.89M-85.47M-9%
Gain YTD-59.16741.040-144%
P/E Ratio12.172.70451%
Revenue172M7.22M2,381%
Total Cash383M117M327%
Total Debt57M61.4M93%
TECHNICAL ANALYSIS
Technical Analysis
TRDATSHA
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 21 days ago
85%
Bullish Trend 22 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFECX23.32N/A
N/A
NAA Large Core C
ENTIX18.44N/A
N/A
ERShares Global Entrepreneurs™ Instl
VSCRX55.83N/A
N/A
Virtus KAR Small-Cap Core R6
THISX77.30N/A
N/A
T. Rowe Price Health Sciences I
HWSZX71.64N/A
N/A
Hotchkis & Wiley Small Cap Value Z

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-0.28%
CRNX - TRDA
57%
Loosely correlated
-1.71%
ARCT - TRDA
52%
Loosely correlated
+4.03%
BEAM - TRDA
52%
Loosely correlated
-2.27%
VYGR - TRDA
51%
Loosely correlated
-2.00%
ATXS - TRDA
51%
Loosely correlated
-1.91%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with XNCR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+2.95%
XNCR - TSHA
40%
Loosely correlated
+3.51%
SLDB - TSHA
40%
Loosely correlated
-2.37%
TRDA - TSHA
39%
Loosely correlated
-0.28%
LRMR - TSHA
39%
Loosely correlated
+8.70%
VYGR - TSHA
39%
Loosely correlated
-2.00%
More